APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drugs based on Genetic Engineering

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drugs based on Genetic Engineering Industry Growth and Trends Forecast to 2032

23 December 2025121 pages

Choose your research edition.

Industry ResearchDrugs based on Genetic Engineering Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs based on Genetic Engineering Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drugs based on Genetic Engineering Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs based on Genetic Engineering Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs based on Genetic Engineering Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global Drugs based on Genetic Engineering market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drugs based on Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drugs based on Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs based on Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drugs based on Genetic Engineering market include GenSci, Takeda, CSPC, 3SBIO, Sandoz, Sanofi, Johnson & Johnson, Novo Nordisk and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drugs based on Genetic Engineering market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs based on Genetic Engineering market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs based on Genetic Engineering market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs based on Genetic Engineering.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drugs based on Genetic Engineering market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs based on Genetic Engineering Market by Company

GenSci

Takeda

CSPC

3SBIO

Sandoz

Sanofi

Johnson & Johnson

Novo Nordisk

Merck

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Biogen

Bayer

Bristol-Myers Squibb

Amgen

AbbVie

Swedish Orphan Biovitrum

Organon Pharma

Drugs based on Genetic Engineering Segment by Type

Recombinant Growth Factor

Recombinant Coagulation Factor

Recombinant Hormone

Recombinant Interferon

Recombinant Interleukin

Fusion Protein

Other

Drugs based on Genetic Engineering Segment by Application

Autoimmune Diseases

Cancers

Metabolic Disorders

Infectious Diseases

Drugs based on Genetic Engineering Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs based on Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs based on Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs based on Genetic Engineering.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drugs based on Genetic Engineering companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drugs based on Genetic Engineering Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drugs based on Genetic Engineering Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drugs based on Genetic Engineering Market Share by Region (2021-2026) Table 4. Global Drugs based on Genetic Engineering Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drugs based on Genetic Engineering Market Share by Region (2027-2032) Table 6. Global Drugs based on Genetic Engineering Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drugs based on Genetic Engineering Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drugs based on Genetic Engineering Market Size Share by Type (2021-2026) Table 9. Global Drugs based on Genetic Engineering Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drugs based on Genetic Engineering Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drugs based on Genetic Engineering Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drugs based on Genetic Engineering Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drugs based on Genetic Engineering Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drugs based on Genetic Engineering Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drugs based on Genetic Engineering Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drugs based on Genetic Engineering Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drugs based on Genetic Engineering Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drugs based on Genetic Engineering Market Size Share by Application (2021-2026) Table 24. Global Drugs based on Genetic Engineering Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drugs based on Genetic Engineering Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drugs based on Genetic Engineering Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drugs based on Genetic Engineering Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drugs based on Genetic Engineering Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drugs based on Genetic Engineering Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drugs based on Genetic Engineering Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drugs based on Genetic Engineering Industry Trends Table 37. Drugs based on Genetic Engineering Industry Drivers Table 38. Drugs based on Genetic Engineering Industry Opportunities and Challenges Table 39. Drugs based on Genetic Engineering Industry Restraints Table 40. Global Drugs based on Genetic Engineering Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drugs based on Genetic Engineering Revenue Market Share by Company (2021-2026) Table 42. Global Drugs based on Genetic Engineering Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drugs based on Genetic Engineering Key Company Headquarters & Area Served Table 44. Global Drugs based on Genetic Engineering Company, Product Type & Application Table 45. Global Drugs based on Genetic Engineering Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drugs based on Genetic Engineering by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GenSci Company Information Table 49. GenSci Business Overview Table 50. GenSci Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GenSci Drugs based on Genetic Engineering Product Portfolio Table 52. GenSci Recent Development Table 53. Takeda Company Information Table 54. Takeda Business Overview Table 55. Takeda Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Takeda Drugs based on Genetic Engineering Product Portfolio Table 57. Takeda Recent Development Table 58. CSPC Company Information Table 59. CSPC Business Overview Table 60. CSPC Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. CSPC Drugs based on Genetic Engineering Product Portfolio Table 62. CSPC Recent Development Table 63. 3SBIO Company Information Table 64. 3SBIO Business Overview Table 65. 3SBIO Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. 3SBIO Drugs based on Genetic Engineering Product Portfolio Table 67. 3SBIO Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sandoz Drugs based on Genetic Engineering Product Portfolio Table 72. Sandoz Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Sanofi Drugs based on Genetic Engineering Product Portfolio Table 77. Sanofi Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Drugs based on Genetic Engineering Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Novo Nordisk Company Information Table 84. Novo Nordisk Business Overview Table 85. Novo Nordisk Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Novo Nordisk Drugs based on Genetic Engineering Product Portfolio Table 87. Novo Nordisk Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Merck Drugs based on Genetic Engineering Product Portfolio Table 92. Merck Recent Development Table 93. Roche Company Information Table 94. Roche Business Overview Table 95. Roche Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Roche Drugs based on Genetic Engineering Product Portfolio Table 97. Roche Recent Development Table 98. Eli Lilly Company Information Table 99. Eli Lilly Business Overview Table 100. Eli Lilly Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Eli Lilly Drugs based on Genetic Engineering Product Portfolio Table 102. Eli Lilly Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Pfizer Drugs based on Genetic Engineering Product Portfolio Table 107. Pfizer Recent Development Table 108. GlaxoSmithKline Company Information Table 109. GlaxoSmithKline Business Overview Table 110. GlaxoSmithKline Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. GlaxoSmithKline Drugs based on Genetic Engineering Product Portfolio Table 112. GlaxoSmithKline Recent Development Table 113. Biogen Company Information Table 114. Biogen Business Overview Table 115. Biogen Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Biogen Drugs based on Genetic Engineering Product Portfolio Table 117. Biogen Recent Development Table 118. Bayer Company Information Table 119. Bayer Business Overview Table 120. Bayer Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Bayer Drugs based on Genetic Engineering Product Portfolio Table 122. Bayer Recent Development Table 123. Bristol-Myers Squibb Company Information Table 124. Bristol-Myers Squibb Business Overview Table 125. Bristol-Myers Squibb Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Bristol-Myers Squibb Drugs based on Genetic Engineering Product Portfolio Table 127. Bristol-Myers Squibb Recent Development Table 128. Amgen Company Information Table 129. Amgen Business Overview Table 130. Amgen Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Amgen Drugs based on Genetic Engineering Product Portfolio Table 132. Amgen Recent Development Table 133. AbbVie Company Information Table 134. AbbVie Business Overview Table 135. AbbVie Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. AbbVie Drugs based on Genetic Engineering Product Portfolio Table 137. AbbVie Recent Development Table 138. Swedish Orphan Biovitrum Company Information Table 139. Swedish Orphan Biovitrum Business Overview Table 140. Swedish Orphan Biovitrum Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product Portfolio Table 142. Swedish Orphan Biovitrum Recent Development Table 143. Organon Pharma Company Information Table 144. Organon Pharma Business Overview Table 145. Organon Pharma Drugs based on Genetic Engineering Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Organon Pharma Drugs based on Genetic Engineering Product Portfolio Table 147. Organon Pharma Recent Development Table 148. North America Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Drugs based on Genetic Engineering Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Drugs based on Genetic Engineering Market Share by Country (2021-2026) Table 151. North America Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Drugs based on Genetic Engineering Market Share Forecast by Country (2027-2032) Table 153. Europe Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Drugs based on Genetic Engineering Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Drugs based on Genetic Engineering Market Share by Country (2021-2026) Table 156. Europe Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Drugs based on Genetic Engineering Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Drugs based on Genetic Engineering Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Drugs based on Genetic Engineering Market Share by Country (2021-2026) Table 161. Asia-Pacific Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Drugs based on Genetic Engineering Market Share Forecast by Country (2027-2032) Table 163. Latin America Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Drugs based on Genetic Engineering Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Drugs based on Genetic Engineering Market Share by Country (2021-2026) Table 166. Latin America Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Drugs based on Genetic Engineering Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Drugs based on Genetic Engineering Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Drugs based on Genetic Engineering Market Share by Country (2021-2026) Table 171. Middle East & Africa Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Drugs based on Genetic Engineering Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drugs based on Genetic Engineering Product Image Figure 3. Global Drugs based on Genetic Engineering Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drugs based on Genetic Engineering Market Size (2021-2032) & (US$ Million) Figure 5. Global Drugs based on Genetic Engineering Market Share by Region: 2025 VS 2032 Figure 6. Global Drugs based on Genetic Engineering Market Share by Region (2021-2032) Figure 7. North America Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Recombinant Growth Factor Image Figure 13. Global Recombinant Growth Factor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Recombinant Coagulation Factor Image Figure 15. Global Recombinant Coagulation Factor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Recombinant Hormone Image Figure 17. Global Recombinant Hormone Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Recombinant Interferon Image Figure 19. Global Recombinant Interferon Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Recombinant Interleukin Image Figure 21. Global Recombinant Interleukin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Fusion Protein Image Figure 23. Global Fusion Protein Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Other Image Figure 25. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Global Drugs based on Genetic Engineering Market Size Overview by Type (2021-2032) & (US$ Million) Figure 27. Global Drugs based on Genetic Engineering Market Share by Type 2025 VS 2032 Figure 28. North America Drugs based on Genetic Engineering Market Size Share by Type (2021-2032) Figure 29. Europe Drugs based on Genetic Engineering Market Size Share by Type (2021-2032) Figure 30. Asia-Pacific Drugs based on Genetic Engineering Market Size Share by Type (2021-2032) Figure 31. Latin America Drugs based on Genetic Engineering Market Size Share by Type (2021-2032) Figure 32. Middle East and Africa Drugs based on Genetic Engineering Market Size Share by Type (2021-2032) Figure 33. Autoimmune Diseases Image Figure 34. Global Autoimmune Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Cancers Image Figure 36. Global Cancers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Metabolic Disorders Image Figure 38. Global Metabolic Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Infectious Diseases Image Figure 40. Global Infectious Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global Drugs based on Genetic Engineering Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Drugs based on Genetic Engineering Market Share by Application 2025 VS 2032 Figure 43. North America Drugs based on Genetic Engineering Market Size Share by Application (2021-2032) Figure 44. Europe Drugs based on Genetic Engineering Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific Drugs based on Genetic Engineering Market Size Share by Application (2021-2032) Figure 46. Latin America Drugs based on Genetic Engineering Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa Drugs based on Genetic Engineering Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 Drugs based on Genetic Engineering Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America Drugs based on Genetic Engineering Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America Drugs based on Genetic Engineering Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America Drugs based on Genetic Engineering Market Share by Country (2021-2032) Figure 53. Europe Drugs based on Genetic Engineering Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Drugs based on Genetic Engineering Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Drugs based on Genetic Engineering Market Share by Country (2021-2032) Figure 56. Asia-Pacific Drugs based on Genetic Engineering Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific Drugs based on Genetic Engineering Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific Drugs based on Genetic Engineering Market Share by Country (2021-2032) Figure 59. Latin America Drugs based on Genetic Engineering Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Drugs based on Genetic Engineering Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Drugs based on Genetic Engineering Market Share by Country (2021-2032) Figure 62. Middle East & Africa Drugs based on Genetic Engineering Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa Drugs based on Genetic Engineering Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa Drugs based on Genetic Engineering Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Growth Factor
  • Recombinant Coagulation Factor
  • Recombinant Hormone
  • Recombinant Interferon
  • Recombinant Interleukin
  • Fusion Protein
  • Other
Applications
  • Autoimmune Diseases
  • Cancers
  • Metabolic Disorders
  • Infectious Diseases
Companies covered
  • GenSci
  • Takeda
  • CSPC
  • 3SBIO
  • Sandoz
  • Sanofi
  • Johnson & Johnson
  • Novo Nordisk
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Biogen
  • Bayer
  • Bristol-Myers Squibb
  • Amgen
  • AbbVie
  • Swedish Orphan Biovitrum
  • Organon Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drugs based on Genetic Engineering Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drugs based on Genetic Engineering Market Size by Region (2021-2032)
  5. 1.4.1 Global Drugs based on Genetic Engineering Market Size by Region (2021-2026)
  6. 1.4.2 Global Drugs based on Genetic Engineering Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drugs based on Genetic Engineering Market Size (2021-2032)
  8. 1.5.1 North America Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drugs based on Genetic Engineering Market Size Growth Rate (2021-2032)
2 Drugs based on Genetic Engineering Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Recombinant Growth Factor
  3. 2.1.2 Recombinant Coagulation Factor
  4. 2.1.3 Recombinant Hormone
  5. 2.1.4 Recombinant Interferon
  6. 2.1.5 Recombinant Interleukin
  7. 2.1.6 Fusion Protein
  8. 2.1.7 Other
  9. 2.2 Global Drugs based on Genetic Engineering Market Size by Type
  10. 2.2.1 Global Drugs based on Genetic Engineering Market Size Overview by Type (2021-2032)
  11. 2.2.2 Global Drugs based on Genetic Engineering Historic Market Size Review by Type (2021-2026)
  12. 2.2.3 Global Drugs based on Genetic Engineering Market Size Forecasted by Type (2027-2032)
  13. 2.3 Global Drugs based on Genetic Engineering Market Size by Regions
  14. 2.3.1 North America Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026)
  15. 2.3.2 Europe Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026)
  16. 2.3.3 Asia-Pacific Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026)
  17. 2.3.4 South America Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026)
  18. 2.3.5 Middle East and Africa Drugs based on Genetic Engineering Market Size Breakdown by Type (2021-2026)
3 Drugs based on Genetic Engineering Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Autoimmune Diseases
  3. 3.1.2 Cancers
  4. 3.1.3 Metabolic Disorders
  5. 3.1.4 Infectious Diseases
  6. 3.2 Global Drugs based on Genetic Engineering Market Size by Application
  7. 3.2.1 Global Drugs based on Genetic Engineering Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Drugs based on Genetic Engineering Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Drugs based on Genetic Engineering Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Drugs based on Genetic Engineering Market Size by Regions
  11. 3.3.1 North America Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Drugs based on Genetic Engineering Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drugs based on Genetic Engineering Industry Trends
  2. 4.2 Drugs based on Genetic Engineering Industry Drivers
  3. 4.3 Drugs based on Genetic Engineering Industry Opportunities and Challenges
  4. 4.4 Drugs based on Genetic Engineering Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drugs based on Genetic Engineering Revenue (2021-2026)
  2. 5.2 Global Drugs based on Genetic Engineering Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drugs based on Genetic Engineering Key Company Headquarters & Area Served
  4. 5.4 Global Drugs based on Genetic Engineering Company, Product Type & Application
  5. 5.5 Global Drugs based on Genetic Engineering Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drugs based on Genetic Engineering Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drugs based on Genetic Engineering Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drugs based on Genetic Engineering Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GenSci
  2. 6.1.1 GenSci Company Information
  3. 6.1.2 GenSci Business Overview
  4. 6.1.3 GenSci Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GenSci Drugs based on Genetic Engineering Product Portfolio
  6. 6.1.5 GenSci Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Drugs based on Genetic Engineering Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 CSPC
  14. 6.3.1 CSPC Company Information
  15. 6.3.2 CSPC Business Overview
  16. 6.3.3 CSPC Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 CSPC Drugs based on Genetic Engineering Product Portfolio
  18. 6.3.5 CSPC Recent Developments
  19. 6.4 3SBIO
  20. 6.4.1 3SBIO Company Information
  21. 6.4.2 3SBIO Business Overview
  22. 6.4.3 3SBIO Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 3SBIO Drugs based on Genetic Engineering Product Portfolio
  24. 6.4.5 3SBIO Recent Developments
  25. 6.5 Sandoz
  26. 6.5.1 Sandoz Company Information
  27. 6.5.2 Sandoz Business Overview
  28. 6.5.3 Sandoz Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sandoz Drugs based on Genetic Engineering Product Portfolio
  30. 6.5.5 Sandoz Recent Developments
  31. 6.6 Sanofi
  32. 6.6.1 Sanofi Company Information
  33. 6.6.2 Sanofi Business Overview
  34. 6.6.3 Sanofi Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Drugs based on Genetic Engineering Product Portfolio
  36. 6.6.5 Sanofi Recent Developments
  37. 6.7 Johnson & Johnson
  38. 6.7.1 Johnson & Johnson Company Information
  39. 6.7.2 Johnson & Johnson Business Overview
  40. 6.7.3 Johnson & Johnson Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Johnson & Johnson Drugs based on Genetic Engineering Product Portfolio
  42. 6.7.5 Johnson & Johnson Recent Developments
  43. 6.8 Novo Nordisk
  44. 6.8.1 Novo Nordisk Company Information
  45. 6.8.2 Novo Nordisk Business Overview
  46. 6.8.3 Novo Nordisk Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Novo Nordisk Drugs based on Genetic Engineering Product Portfolio
  48. 6.8.5 Novo Nordisk Recent Developments
  49. 6.9 Merck
  50. 6.9.1 Merck Company Information
  51. 6.9.2 Merck Business Overview
  52. 6.9.3 Merck Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Merck Drugs based on Genetic Engineering Product Portfolio
  54. 6.9.5 Merck Recent Developments
  55. 6.10 Roche
  56. 6.10.1 Roche Company Information
  57. 6.10.2 Roche Business Overview
  58. 6.10.3 Roche Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Roche Drugs based on Genetic Engineering Product Portfolio
  60. 6.10.5 Roche Recent Developments
  61. 6.11 Eli Lilly
  62. 6.11.1 Eli Lilly Company Information
  63. 6.11.2 Eli Lilly Business Overview
  64. 6.11.3 Eli Lilly Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Eli Lilly Drugs based on Genetic Engineering Product Portfolio
  66. 6.11.5 Eli Lilly Recent Developments
  67. 6.12 Pfizer
  68. 6.12.1 Pfizer Company Information
  69. 6.12.2 Pfizer Business Overview
  70. 6.12.3 Pfizer Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Pfizer Drugs based on Genetic Engineering Product Portfolio
  72. 6.12.5 Pfizer Recent Developments
  73. 6.13 GlaxoSmithKline
  74. 6.13.1 GlaxoSmithKline Company Information
  75. 6.13.2 GlaxoSmithKline Business Overview
  76. 6.13.3 GlaxoSmithKline Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 GlaxoSmithKline Drugs based on Genetic Engineering Product Portfolio
  78. 6.13.5 GlaxoSmithKline Recent Developments
  79. 6.14 Biogen
  80. 6.14.1 Biogen Company Information
  81. 6.14.2 Biogen Business Overview
  82. 6.14.3 Biogen Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Biogen Drugs based on Genetic Engineering Product Portfolio
  84. 6.14.5 Biogen Recent Developments
  85. 6.15 Bayer
  86. 6.15.1 Bayer Company Information
  87. 6.15.2 Bayer Business Overview
  88. 6.15.3 Bayer Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Bayer Drugs based on Genetic Engineering Product Portfolio
  90. 6.15.5 Bayer Recent Developments
  91. 6.16 Bristol-Myers Squibb
  92. 6.16.1 Bristol-Myers Squibb Company Information
  93. 6.16.2 Bristol-Myers Squibb Business Overview
  94. 6.16.3 Bristol-Myers Squibb Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Bristol-Myers Squibb Drugs based on Genetic Engineering Product Portfolio
  96. 6.16.5 Bristol-Myers Squibb Recent Developments
  97. 6.17 Amgen
  98. 6.17.1 Amgen Company Information
  99. 6.17.2 Amgen Business Overview
  100. 6.17.3 Amgen Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Amgen Drugs based on Genetic Engineering Product Portfolio
  102. 6.17.5 Amgen Recent Developments
  103. 6.18 AbbVie
  104. 6.18.1 AbbVie Company Information
  105. 6.18.2 AbbVie Business Overview
  106. 6.18.3 AbbVie Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 AbbVie Drugs based on Genetic Engineering Product Portfolio
  108. 6.18.5 AbbVie Recent Developments
  109. 6.19 Swedish Orphan Biovitrum
  110. 6.19.1 Swedish Orphan Biovitrum Company Information
  111. 6.19.2 Swedish Orphan Biovitrum Business Overview
  112. 6.19.3 Swedish Orphan Biovitrum Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product Portfolio
  114. 6.19.5 Swedish Orphan Biovitrum Recent Developments
  115. 6.20 Organon Pharma
  116. 6.20.1 Organon Pharma Company Information
  117. 6.20.2 Organon Pharma Business Overview
  118. 6.20.3 Organon Pharma Drugs based on Genetic Engineering Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Organon Pharma Drugs based on Genetic Engineering Product Portfolio
  120. 6.20.5 Organon Pharma Recent Developments
7 North America
  1. 7.1 North America Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drugs based on Genetic Engineering Market Size by Country (2021-2026)
  3. 7.3 North America Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drugs based on Genetic Engineering Market Size by Country (2021-2026)
  3. 8.3 Europe Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drugs based on Genetic Engineering Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drugs based on Genetic Engineering Market Size by Country (2021-2026)
  3. 10.3 South America Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drugs based on Genetic Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drugs based on Genetic Engineering Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drugs based on Genetic Engineering Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst